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Abstract: Chronic exposure to tobacco smoke leads to chronic low-grade systemic inflammation;
however, little is known about the dose-dependent toxic effect of objective tobacco smoking on
systemic inflammation. We examined the dose-dependent toxic effect of cotinine-verified tobacco
smoking on leukocyte count in a representative sample of Korean adults, including 8655 men and
10,432 women aged 19–65 years from the Korean National Health and Nutrition Examination Survey.
The participants were categorized into five groups by the level of urine cotinine (Ucot) as follows:
A non-smoker group (<50.00 ng/mL) and four quartile groups for smokers for both men and women.
The odds ratios (ORs) and 95% confidence intervals (CIs) for sex-specific high leukocyte count
(≥75th percentile) were calculated across five groups of Ucot concentrations using multiple logistic
regression analyses. The mean values of leukocyte count gradually increased according to the grade
of Ucot concentration in both sexes. The ORs (95% CIs) for high leukocyte count in the 4th Ucot
quartile concentrations versus the non-smokers were 4.09 (3.39–4.94) for men and 3.91 (2.82–5.41)
for women after adjusting for confounding variables. The present study confirmed the dose-response
toxic effect of tobacco smoking on chronic low-grade systemic inflammation.
Keywords: tobacco smoking; cotinine; leukocyte count; inflammation
1. Introduction
Tobacco smoking is a major risk factor for morbidity and mortality from cardiovascular disease
(CVD) [1], which is now increasingly viewed as inflammatory disease [2]. Leukocyte count is a
simple, easy to obtain, and economical marker of systemic inflammation for clinical practice. A higher
leukocyte count, even within the normal range, has been associated with increased incidence risk of
hypertension, type 2 diabetes mellitus, CVD, all-cause mortality risk, and cancers [2–5].
Many toxins in tobacco such as nicotine, carbon monoxide, benzene, and many other reactive
oxidants provoke systemic inflammation by a variety of mechanisms [6]. For the acute phase of
smoking, activation of airway epithelial cells stimulates immune cells such as neutrophils and
macrophages in the respiratory system, whereas chronic exposure to tobacco smoke leads to chronic
low-grade systemic inflammation [7,8].
Although previous studies have reported that several inflammatory markers are increased
in current smokers, most studies used a self-reported questionnaire such as smoking status
(never, ex-smoker, and current smokers) or the average number of cigarettes smoked per day [9–11].
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However, self-reported tobacco smoking may not always represent an individual’s true smoking status,
because the smoking rate might be underestimated particularly in females due to the possibility of
false response and recall bias [12,13].
Cotinine, a specific metabolite of nicotine in tobacco, is widely used as a quantitative biomarker
of tobacco smoke exposure [14]. Due to its long half-life of approximately 16–20 h in the body [15],
cotinine is detectable for several days after tobacco smoking. For this reason, the dose-dependent risk
estimates for detrimental clinical outcomes related to tobacco smoking have been evaluated using
cotinine (Ucot) concentrations [16–18]. To date, little is known about the dose-dependent toxic effect of
objective tobacco smoking on systemic inflammation. Thus, we examined the dose-dependent toxic
effect of cotinine-verified tobacco smoking on leukocyte count, a useful systemic inflammatory marker
in clinical practice, from a representative sample of Korean adult men and women.
2. Materials and Methods
2.1. Study Population
This study was based on data obtained from the 2008–2015 Korean National Health and Nutrition
Examination Survey (KNHANES), a cross-sectional and nationally representative survey conducted
by the Korean Ministry of Health and Welfare. The target population of KNHANES represents
non-institutionalized civilians who are aged older than 1 year in Korea. Citizens were informed that
they had been randomly selected as a household to voluntarily participate in a nationally representative
survey conducted by the Korean Ministry of Health and Welfare (KCDC) and that they had the
right to refuse to participate in accordance with the National Health Enhancement Act supported
by the National Statistics Law of Korea. The participants provided written informed consent to
participate in the study. The Korea Centers for Disease Control and Prevention obtained consent from
participants to use blood samples for additional academic purposes. The KNHANES was approved
by the Institutional Review Board of the KCDC (IRB No. 2008-04EXP-01-C, 2009-01CON-03-2C,
2010-02CON-21-C, 2011-02CON-06-C, 2012-01EXP-01-2C, 2013-07CON-03-4C, and 2013-12EXP-03-5C).
We extracted 27,734 participants (13,034 men and 14,700 women) aged 19–65 years whose Ucot data
were available from the 2008, 2009, 2010, 2011, 2014, and 2015 KNHANES datasets. We excluded
participants who met at least one of the following criteria (n = 8647): A history of cancer, coronary
artery disease, cerebrovascular disease, pulmonary tuberculosis, asthma, and chronic obstructive lung
disease, rheumatologic disease, liver cirrhosis, or chronic kidney disease; electronic cigarette users;
subjects with nicotine replacement therapy; non-smokers with second-hand tobacco exposure at the
workplace and home; subjects with leukocyte counts ≥10,000 cells/µL; and those with missing data
or those who did not fast for 12 h prior to testing. Following these exclusions, 19,087 participants
(8655 men and 10,432 women) were included in our final analysis.
2.2. Data Collection
The sampling units were households selected through a stratified, multistage, probability-based
sampling design based on geographic area, sex, and age group using household registries. Sampling
weights indicating the probability of being sampled were assigned to each participant, thus producing
results that represent the entire Korean population. Participants completed four parts of a questionnaire
that consisted of a health interview survey, a health behavior survey, a health examination survey,
and a nutrition survey. Trained staff reviewed the completed questionnaires and entered responses
into a database.
Self-reported cigarette smoking, alcohol consumption, and physical activity were determined
from the questionnaires. Each participant was categorized as a non-smoker, ex-smoker, or current
smoker with respect to smoking status. Participants were also asked about the frequency of alcohol
intake and leisure-time physical activity on a weekly basis. Alcohol intake was divided into none,
≤once per week, and ≥two times per week. Regular exercise was divided into three groups according
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to frequency of moderate intensity exercise: None, ≤two times per week, and ≥three times per
week. Educational level was classified as middle school or below, high school, and college or above.
Household income was classified into four quartiles from the lowest to the highest. Occupation was
classified into three categories: Unemployed (retired, students, and housewives); blue-collar workers
(agriculture, forestry, fishery workers, craft and related trade workers, plant and machine operators and
assemblers, and elementary occupations); white-collar workers (managers, professionals, technicians,
clerks, and service/sales workers) according to the Korean Standard Classification of Occupations.
The health examinations included a medical history, a physical examination, and anthropometric
and biochemical measurements. If participants were being treated for any disease, they were asked
for data regarding their diagnosis as well as a list of medications currently being taken. Physical
examinations were performed by trained medical staff following standardized procedures. Height
and weight were recorded to the nearest 0.1 cm (Seca 225, Seca, Hamburg, Germany) and 0.1 kg,
respectively (GL-6000-20, G-tech, Seoul, Korea). Body mass index (BMI) was calculated as the
ratio of weight (kg)/height (m)2. Systolic and diastolic blood pressure were measured using the
patient’s right arm with a standard mercury sphygmomanometer (Baumanometer; W. A. Baum Co
Inc., Copiague, NY, USA). Mean arterial pressure was calculated using the equation (SBP + 2*DBP)/3.
Leukocyte count was determined by an automated blood cell counter (XE-2100D, Sysmex, Kobe,
Japan). Fasting plasma glucose, triglyceride, and high-density lipoprotein (HDL) cholesterol levels
were measured by enzymatic methods using a Hitachi 7600-110 automated chemistry analyzer (Hitachi,
Tokyo, Japan). Participants were requested to submit early morning samples of 5–20 mL urine.
Ucot concentrations were measured by gas chromatographic mass spectrometry using a PerkinElmer
Clarus 600T instrument (PerkinElmer, Waltham, MA, USA). The cut-off values of cotinine-verified
current smoking ranged between 31.5 and 550 ng/mL in previous studies [19–21]. We classified
participants with Ucot concentrations above or equal to 50 ng/mL as cotinine-verified current smoker
according to the recommendation by the Society for Research on Nicotine and Tobacco [22], which have
been validated in previous studies [23–25].
2.3. Statistical Analysis
All statistical analyses were performed using SAS software, version 9.4 (SAS Institute Inc.,
Cary, NC, USA), which incorporates sample weights and adjusts for the complex sample design
of the survey. All statistical tests were two-sided and statistical significance was determined at
p < 0.05. The survey sample weights were used to produce estimates that are representative of
Korean adult men and women. To examine the dose-response relationship between cotinine-verified
smoking and high leukocyte count, Ucot concentrations were categorized into five groups as follows:
A non-smoker group (<50.00 ng/mL) and four quartile groups for smokers (Q1: 50.00–589.29 ng/mL,
Q2: 722.57–1,254.73 ng/mL, Q3: 1,177.92–1,826.40 ng/mL, and Q4: ≥1,826.41 ng/mL) for men
and (Q1: 50.00–162.79 ng/mL, Q2: 162.80–556.62 ng/mL, Q3: 556.63–1,073.13 ng/mL, and Q4:
≥1,073.14 ng/mL) for women. The characteristics of the study population were summarized using the
weighted one-way analysis of variance (ANOVA) test for continuous variables and weighted chi-square
test for categorical variables. The odds ratios (ORs) and 95% confidence intervals (CIs) for high
leukocyte count (≥75th percentile in the current sample, ≥7350 cells/µL for men and 6630 cells/µL
for women) were calculated across the five groups of Ucot concentrations using multivariate logistic
regression analysis after adjusting for confounding variables.
3. Results
The characteristics of the study population according to Ucot concentrations are described in
Tables 1 and 2. The mean values of age and mean arterial pressure were highest in nonsmokers for
both men and women. The prevalence of self-reported current smoking was 43.5% in men and 6.1%
in women, whereas the prevalence of cotinine-verified current smoking was 46.5% in men and 11.5%
in women. The mean values of BMI were lowest in the 4th Ucot quartile for both men and women.
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The mean values of triglycerides were highest in the 4th Ucot quartile for both men and women.
The proportion of alcohol drinking ≥two times per week was highest whereas the education level
of college or above was lowest in the 4th Ucot quartile for both men and women. The proportion of
highest household income (Q4) was highest in nonsmokers for men and 1st Ucot quartile for women.
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Table 1. Characteristics of the study population according to urine cotinine concentrations in men.
Total Nonsmokers Urine Cotinine Quartiles in Smokers (ng/mL)
Q1 (50.00–589.29) Q2 (589.3–1177.91) Q3 (1177.92–1826.40) Q4 (≥1826.41) p-Value
N 8655 4814 960 960 959 962
Age (years) 42.2 (0.2) 43.9 (0.2) 43.3 (0.5) 40.0 (0.4) 40.9 (0.4) 41.3 (0.4) <0.001
Body mass index (kg/m2) 24.2 (0.0) 24.3 (0.1) 24.3 (0.1) 24.2 (0.1) 24.2 (0.1) 23.7 (0.1) 0.004
Mean arterial pressure (mmHg) 92.4 (0.2) 92.7 (0.2) 91.9 (0.4) 91.2 (0.4) 92.3 (0.4) 92.1 (0.4) 0.014
Fasting plasma glucose (mg/dl) 98.8 (0.2) 99.3 (0.3) 99.5 (1.1) 99.5 (0.9) 98.3 (0.7) 95.9 (0.6) <0.001
Triglyceride (mg/dl) 160.9 (1.7) 150.5 (2.4) 159.9 (4.9) 177.1 (5.0) 170.8 (6.1) 183.9 (5.3) <0.001
HDL cholesterol (mg/dl) 47.5 (0.2) 47.7 (0.2) 48.7 (0.6) 47.2 (0.6) 46.6 (0.6) 46.4 (0.6) 0.075
Self-reported smoking status (%) <0.001
Never smoker 23.8 (0.5) 42.9 (0.9) 5.0 (0.8) 0.9 (0.3) 0.2 (0.1) 0.5 (0.2)
Ex-smoker 32.7 (0.5) 54.7 (0.8) 19.2 (1.5) 6.5 (1.1) 3.0 (0.6) 0.8 (0.2)
Current smoker 43.5 (0.6) 2.4 (0.2) 75.8 (1.7) 92.6 (1.1) 96.8 (0.7) 98.7 (0.4)
Alcohol intake (%) <0.001
Non-drinker 7.8 (0.3) 10.2 (0.5) 4.3 (0.7) 4.2 (0.6) 6.3 (0.9) 5.6 (0.8)
Once/week 54.1 (0.6) 58.5 (0.9) 52.3 (1.9) 54.1 (1.8) 45.5 (1.9) 44.6 (1.9)
≥2 times/week 38.1 (0.6) 31.3 (0.8) 43.4 (1.9) 41.7 (1.8) 48.2 (1.9) 49.8 (1.9)
Regular exercise (%) 0.532
None 48.8 (0.8) 48.5 (1.2) 47.1 (2.2) 49.2 (2.3) 49.2 (2.2) 50.7 (2.4)
1–2 times/week 23.5 (0.7) 23.7 (0.9) 26.3 (1.9) 24.1 (1.8) 23.1 (1.8) 19.5 (1.8)
≥3 times/week 27.7 (0.7) 27.8 (1.0) 26.6 (1.9) 26.7 (2.0) 27.7 (2.1) 29.8 (2.2)
Education level (%) <0.001
≤middle school 17.6 (0.5) 17.8 (0.6) 15.7 (1.2) 16.3 (1.4) 17.1 (1.3) 19.7 (1.4)
High school 42.6 (0.7) 40.6 (0.9) 40.5 (2.0) 45.5 (1.9) 47.0 (1.9) 47.1 (1.9)
≥college 39.8 (0.7) 41.6 (0.9) 43.8 (2.1) 38.2 (1.8) 35.9 (1.8) 33.2 (1.9)
Household income (%) 0.027
1st quartile 10.9 (0.4) 10.4 (0.5) 11.6 (1.1) 12.5 (1.2) 11.5 (1.1) 10.4 (1.1)
2nd quartile 24.8 (0.6) 24.1 (0.8) 24.1 (1.5) 27.2 (1.7) 25.0 (1.6) 25.6 (1.6)
3rd quartile 31.3 (0.6) 30.3 (0.8) 32.4 (1.9) 32.0 (1.8) 31.0 (1.7) 34.8 (1.8)
4th quartile 33.0 (0.8) 35.2 (1.0) 31.9 (1.9) 28.3 (1.7) 32.5 (1.8) 29.2 (1.7)
Occupation (%) <0.001
Unemployed 21.0 (0.5) 24.0 (0.8) 20.6 (1.6) 19.8 (1.5) 15.9 (1.4) 13.5 (1.3)
Blue-collar workers 34,.8 (0.7) 31.7 (0.9) 30.9 (1.7) 35.0 (1.8) 41.7 (1.9) 46.0 (1.9)
White-collar workers 44.2 (0.7) 44.3 (0.9) 48.5 (1.9) 45.2 (1.9) 42.4 (1.9) 40.5 (1.9)
Data are expressed as the mean (SE) or percentage (SE). p values were calculated using weighted one-way ANOVA test or weighted chi-square test.
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Table 2. Characteristics of the study population according to urine cotinine concentrations in women.
Total Nonsmokers Urine Cotinine Quartiles in Smokers (ng/mL)
Q1 (50.00–162.79) Q2 (162.80–556.62) Q3 (556.63–1073.13) Q4 (≥1073.14) p-value
N 10,342 9329 275 276 276 276
Age (years) 44.6 (0.2) 45.1 (0.2) 41.0 (1.0) 38.4 (1.0) 40.1 (0.9) 42.1 (0.9) <0.001
Body mass index (kg/m2) 23.1 (0.0) 23.1 (0.0) 23.1 (0.3) 22.7 (0.2) 22.9 (0.2) 22.2 (0.2) 0.004
Mean arterial pressure (mmHg) 86.3 (0.2) 86.5 (0.1) 84.8 (0.7) 84.9 (0.8) 85.1 (0.7) 84.8 (0.7) 0.004
Fasting plasma glucose (mg/dl) 95.1 (0.2) 95.3 (0.2) 94.4 (1.1) 93.8 (1.0) 94.6 (1.2) 93.4 (1.1) 0.313
Triglyceride (mg/dl) 108.6 (0.9) 107.3 (0.8) 106.9 (5.9) 116.7 (5.9) 121.5 (5.2) 129.1 (7.0) <0.001
HDL cholesterol (mg/dl) 54.7 (0.2) 54.6 (0.2) 55.2 (1.9) 56.4 (1.3) 55.9 (1.4) 55.1 (1.2) 0.519
Self-reported current smoking (%) <0.001
Never smoker 87.5 (0.4) 93.7 (0.3) 74.2 (3.4) 36.5 (3.4) 27.0 (3.1) 26.3 (3.3)
Ex-smoker 6.4 (0.3) 5.9 (0.3) 11.5 (2.3) 13.8 (2.6) 7.1 (1.8) 7.8 (1.8)
Current smoker 6.1 (0.3) 0.4 (0.1) 14.4 (2.9) 49.7 (3.6) 65.9 (3.4) 65.9 (3.4)
Alcohol intake (%) <0.001
Non-drinker 18.4 (0.5) 19.4 (0.5) 11.5 (2.2) 9.2 (1.7) 18.0 (2.6) 8.1 (1.9)
Once/week 68.8 (0.6) 70.0 (0.6) 65.8 (3.6) 59.3 (3.3) 57.8 (3.6) 58.4 (3.6)
≥2 times/week 12.8 (0.4) 10.5 (0.4) 22.7 (3.3) 31.5 (3.1) 24.2 (3.1) 33.5 (3.5)
Regular exercise (%) 0.758
None 59.7 0.9) 59.7 (0.9) 58.9 (3.6) 59.3 (4.2) 55.3 (4.2) 63.2 (4.3)
1–2 times/week 15.8 (0.6) 15.9 (0.6) 18.7 (2.8) 14.1 (3.0) 14.3 (3.2) 14.6 (3.4)
≥3 times/week 24.5 (0.8) 24.4 (0.8) 22.4 (3.0) 26.6 (3.7) 30.4 (3.7) 22.2 (3.6)
Education level (%) <0.001
≤middle school 29.4 (0.6) 30.1 (0.6) 23.9 (2.9) 18.0 (2.9) 27.3 (2.8) 29.8 (3.0)
High school 38.4 (0.7) 33.7 (0.6) 42.8 (3.5) 53.5 (3.6) 53.8 (3.5) 52.1 (3.4)
≥college 32.2 (0.7) 33.2 (0.7) 33.3 (3.5) 28.5 (3.3) 18.9 (2.7) 18.0 (2.7)
Household income (%) <0.001
1st quartile 14.9 (0.4) 14.8 (0.4) 13.8 (2.3) 13.8 (2.3) 16.6 (2.4) 19.8 (2.6)
2nd quartile 26.0 (0.6) 25.1 (0.6) 30.9 (3.3) 30.5 (3.3) 34.3 (3.5) 36.1 (3.4)
3rd quartile 28.8 (0.6) 29.4 (0.6) 23.2 (2.8) 24.8 (3.2) 21.0 (2.7) 24.4 (3.2)
4th quartile 30.3 (0.8) 30.6 (0.8) 32.1 (3.4) 30.9 (3.3) 28.1 (3.7) 19.7 (2.9)
Occupation (%) 0.714
Unemployed 45.9 (0.6) 48.2 (0.6) 46.2 (3.6) 46.7 (3.6) 45.7 (3.6) 43.3 (3.5)
Blue-collar workers 15.7 (0.5) 15,7 (0.5) 15.3 (2.3) 12.3 (2.3) 15.7 (3.3) 17.8 (2.6)
White-collar workers 35.4 (0.6) 36.1 (0.6) 38.5 (3.7) 41.0 (3.5) 38.6 (3.4) 38.9 (3.5)
Data are expressed as the mean (SE) or percentage (SE). p values were calculated using weighted one-way ANOVA test or weighted chi-square test.
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Figure 1 shows the mean values of leukocyte counts according to the five groups of Ucot
concentrations. The overall leukocyte count mean value gradually increased according to the grade
of Ucot concentration: 6117, 6438, 6720, 7000, and 7170 cells/µL for men and 5761, 5971, 6107,
and 6824 cells/µL for women (All p values < 0.001).
1 
 
 Figure 1. The mean values of leukocyte count according to urine cotinine concentrations (bars mean
standard error).
Table 3 shows the dose-response relationship between Ucot concentrations and high leukocyte
counts. Compared with the cotinine-verified non-smoker group, the ORs (95% CIs) of high leukocyte
count in terms of the quartiles of Ucot concentrations in current smokers were 1.70 (1.38–2.09),
2.35 (1.92–2.88), 3.54 (2.93–4.28), and 4.09 (3.39–4.94) for men and 1.02 (0.71–1.45), 1.42 (1.03–1.94),
1.58 (1.14–2.19), 3.91 (2.82–5.41) for women after adjusting for age, BMI, alcohol intake, education level,
household income, occupation, and triglyceride level.
Table 3. Odds ratios and 95% confidence intervals for high leukocyte count according to urine
cotinine concentrations.
Urine Cotinine Quartiles in Smokers (ng/mL)
Men Nonsmokers Q1 Q2 Q3 Q4 p for trend
Model 1 1.00 1.56 (1.38–1.90) 2.29 (1.89–2.77) 3.37 (2.83–4.02) 3.85 (3.23–4.57) <0.001
Model 2 1.00 1.64 (1.34–2.01) 2.37 (1.95–2.89) 3.42 (2.85–4.11) 3.80 (3.17–4.55) <0.001
Model 3 1.00 1.70 (1.38–2.09) 2.35 (1.92–2.88) 3.54 (2.93–4.28) 4.09 (3.39–4.94) <0.001
Women Nonsmokers Q1 Q2 Q3 Q4 p for trend
Model 1 1.00 1.02 (0.72–1.42) 1.36 (1.02–1.81) 1.57 (1.16–2.11) 4.17 (3.11–5.60) <0.001
Model 2 1.00 0.99 (0.70–1.41) 1.46 (1.07–1.98) 1.59 (1.16–2.17) 4.32 (3.14–5.96) <0.001
Model 3 1.00 1.02 (0.71–1.45) 1.42 (1.03–1.94) 1.58 (1.14–2.19) 3.91 (2.82–5.41) <0.001
Model 1: Adjusted for age and body mass index. Model 2: Adjusted for age, body mass index, and alcohol intake.
Model 3: Adjusted for age, body mass index, alcohol intake, education level, household income, occupation and
triglyceride level.
4. Discussion
In this large, population-based cross-sectional study, Ucot concentrations were independently
and positively associated with systemic inflammation as measured by leukocyte counts in a
dose-response manner for both men and women. Compared with the cotinine-verified non-smoker
group, which was the reference group of this study, the odds ratio (OR) for high leukocyte count
in the highest quartile group of Ucot concentrations was approximately four times higher after
adjusting for potential confounding variables. The positive association between cotinine-verified
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smoking and leukocyte count is compatible with the findings of previous studies [26,27]. It has
been demonstrated that current smokers have higher levels of inflammatory markers than people
who have never smoked [28]. Kawada et al. reported that leukocyte count was higher in smokers
and ex-smokers than in non-smokers, and elevated leukocyte counts were maintained for several
years after smoking cessation [27]. A previous study also found a positive association between
smoking status categorized into non-smoker, ex-smoker, and current smoker and leukocyte counts
among 416,065 Korean adults [29]. However, most previous studies estimated smoke exposure
using self-reported questionnaires, which have several limitations such as response inaccuracy or
omissions of second-hand tobacco smoke exposure [12,13]. In the present study, we found the notable
discrepancy between self-reported smoking and cotinine-verified smoking rate particularly in women.
The prevalence of cotinine-verified smoking rate in women was approximately two times higher
than that of self-reported smoking (11.5% vs. 6.1%), consistent with previous findings implicating
that the smoking rate is likely to be underestimated on basis of self-reported questionnaire in studies
targeting the female population [12,13]. As described earlier, the accurate analysis of dose-effect
relationships of tobacco smoking could be affected by smoking habits such as the degree of inhalation,
smoking cessation duration, and type of tobacco. To overcome these limitations, we used Ucot
concentration, a reliable, quantitative biomarker of tobacco smoke exposure. Among the various
biochemical markers of tobacco smoke exposure, Ucot has been commonly used in prevalent surveys
to validate self-reported smoking status due to its higher stability and longer half-life [19].
Although the underlying biological mechanisms that explain smoking-induced increases in
leukocyte count are not fully understood, there are several lines of evidence suggesting that tobacco
smoking has the ability to evoke an inflammatory response through direct or indirect pathways.
Tobacco smoking chronically stimulates the airway tract and subsequently may increase leukocyte
count. Many toxins such as carbon monoxide, benzene, benzopyrene, and many other reactive
oxidant substances during tobacco smoking activate inflammation in respiratory tracts in a direct
manner, resulting in the production of potent inflammatory mediators such as tumor necrosis factor
(TNF)-α, and interleukins [7,27,29,30]. Moreover, the pro-inflammatory cytokines induced by chronic
exposure to tobacco smoke indirectly lead to systemic low-grade inflammation beyond the respiratory
system [7,30–32].
In the present study, we used serum leukocyte count as an indicator of low-grade systemic
inflammation. Leukocyte count is a simple, easy to obtain, and useful inflammatory marker in
clinical practice. In addition to a marker of acute infection, high leukocyte count, even within
the normal range, has been positively associated with all-cause mortality and incidence risk of
cardiovascular diseases [4,5]. Moreover, numerous studies repeatedly demonstrated that leukocyte
count is an independent predictor of the initiation and progression of inflammatory processes related
to cardiometabolic diseases [2,3]. Thus, high leukocyte count could be used as a useful biomarker with
reflecting low-grade systemic inflammation.
There are some limitations of the present study that should be considered when interpreting its
findings. First, this study was a cross-sectional study by design and thus it was not possible to establish
a causal relationship between Ucot concentration and leukocyte counts. However, it is more likely that
smoking causes inflammation rather than inflammation causing smoking. Second, leukocyte counts in
this study were only measured once, and thus it was not possible to determine whether an acute and
brief episode of infection or chronic inflammation was responsible for the observed correlation. In order
to reduce this potential error, we excluded subjects with leukocyte counts ≥10,000 cells/µL. Moreover,
we did not exclude the presence of allergic diseases which may affect leukocyte count. Lastly, most of
the tobacco users in Korean population are cigarette smokers, so our results may not be applied to
other populations who mainly use other types of tobacco such as oral tobacco products. Despite these
potential limitations, our study has also several strengths. First, the findings of the present study can be
generalized because the KNHANES dataset represents the entire Korean population. Second, this study
assessed objective tobacco smoking by Ucot concentrations and excluded the second-hand tobacco
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smoke exposure in non-smokers to minimize the information and misclassification bias on tobacco use.
Lastly, this study controlled comprehensive confounding variables including both sociodemographic
and laboratory parameters in regression analysis models, as compared to previous studies [26,28].
5. Conclusions
In conclusion, the present study confirmed a dose-response toxic effect of tobacco smoking,
as measured by Ucot concentrations on low-grade systemic inflammation. Our results indicate that
high leukocyte count could be another useful indicator of tobacco smoke exposure in a dose-response
manner. Moreover, future prospective studies with a larger number of participants over a longer
period of time are warranted to investigate the impact of smoking cessation on leukocyte count.
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